SCHEMBL2126124

SCHEMBL2126124

COc1cccc(-c2sc(N(C)C)nc2C(=O)N2[C@@H]3CC[C@@H](C3)[C@H]2C(N)=O)c1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 17/20 0.41
HCRTR2 O43614 17/20 0.41
ALDH1A1 P00352 2/20 0.38
RAB9A P51151 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
IKBKB O14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2128526 0.92 HCRTR1 (0.41) HCRTR1HCRTR2ALDH1A1RAB9ANPC1
SCHEMBL2126110 0.89 HCRTR1 (0.40) HCRTR1HCRTR2RAB9ANPC1
SCHEMBL2127892 0.88 HCRTR1 (0.47) HCRTR1HCRTR2
SCHEMBL2127631 0.88 HCRTR1 (0.40) HCRTR1HCRTR2
SCHEMBL2127888 0.88 HCRTR1 (0.47) HCRTR1HCRTR2
SCHEMBL2126102 0.88 HCRTR1 (0.44) HCRTR1HCRTR2
SCHEMBL2126133 0.87 HCRTR1 (0.41) HCRTR1HCRTR2ALDH1A1RAB9AKDM4E
SCHEMBL2127097 0.86 HCRTR1 (0.39) HCRTR1HCRTR2
SCHEMBL2125619 0.84 HCRTR1 (0.45) HCRTR1HCRTR2
SCHEMBL2125623 0.84 HCRTR1 (0.45) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8236801-B2 2-aza-bicyclo[2.2.1]heptane derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2012-08-07 US claimed
EP-2247586-B1 2-AZA-BICYCLO[2.2.1]HEPTANE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2012-04-25 EP claimed
US-8236801-B2 2-aza-bicyclo[2.2.1]heptane derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2012-08-07 US disclosed